It has been demonstrated to protect against CRC by suppressing the activity and expression of DNA methyltransferase enzymes (DNMT1 and DNMT3B) and demethylating WNT upstream regulators (CDKN2A, SFRP2, SFRP5, and WIF1) (41). This evidence concerns the gene SFRP2 and colorectal carcinoma.